ATEC to Participate in Upcoming Investor Conferences - November 01, 2023

01 Nov 2023
www.biospace.com
CARLSBAD, Calif.--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor events: The Stifel Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, with a fireside chat at 3:00pm ET on November 14, 2023 The Jefferies London Healthcare Conference at the Waldorf Hilton in Aldwych, London, with a fireside chat at 2:30pm GMT on November 16, 2023 The Piper Sandler Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, with a fireside chat at 12:00pm ET on November 28, 2023 The Truist Securities MedTech West Coast Bus Tour will visit ATEC Headquarters at 10:00am PT on December 6, 2023 The Stifel Medtech Madness West Coast Bus Tour at the Montage Laguna Beach in Laguna Beach, CA, with a fireside chat at 10:15am PT on December 11, 2023 Webcasts of the conference presentations and archived recordings will be available in the Investor Relations Section of the Company’s website. About ATEC ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation MachineTM is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine. For more information, visit us at . View source version on businesswire.com: Contacts Investor/Media Contact: Tina Jacobsen, CFA Investor Relations (760) 494-6790 investorrelations@atecspine.com Company Contact: J. Todd Koning Chief Financial Officer Alphatec Holdings, Inc. investorrelations@atecspine.com Source: Alphatec Holdings, Inc. View this news release online at:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.